Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Nov 3, 2006

Dutch Government Invests EUR 18M in TB Vaccine Development

  • The Dutch Ministry of Foreign Affairs  made a EUR 18.4-million, four-year investment in Aeras Global TB Vaccine Foundation, a product development partnership that is collaborating with Crucell, KNCV Tuberculosis Foundation, Netherlands Cancer Institute, and other Dutch organizations to develop new TB vaccines.

    In Aeras’ prime-boost strategy, an improved TB vaccine, the prime, will be given initially, and another type of vaccine, the boost, will be given at a specified period of time after the prime vaccination. One of the foundation’s products, Aeras 402/Crucell Adenovirus35 TB vaccine, recently entered clinical trials.



Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »